The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study

Emanuele D’Amico, Carmela Leone, Giusi Graziano, Maria Pia Amato, Roberto Bergamaschi, Paola Cavalla, Gabriella Coniglio, Giancarlo Di Battista, Maria Teresa Ferrò, Franco Granella, Enrico Granieri, Alessandra Lugaresi, Giacomo Lus, Enrico Millefiorini, Carlo Pozzilli, Gioacchino Tedeschi, Mario Zappia, Giancarlo Comi, Maria Trojano, Vito Lepore and Francesco Patti

PLOS ONE, 2016, vol. 11, issue 6, 1-11

Abstract: Introduction: Immunosuppressive agents (ISA) have been used in multiple sclerosis (MS) for decades, frequently as off label licensed therapies. Given the new MS treatment landscape, what place do ISA have in combating MS? Methods: We conducted a retrospective multicentre study to investigate the frequency of ISA prescription in 17 Italian MS centres, and to describe the clinical factors related to ISA use. Results: Out of 6,447 MS patients, 2,034 (31.6%) were treated with ISA, with Azathioprine being the most frequently used ISA overall. MS patients treated with ISA alone were more frequently affected by the progressive course (both primary and secondary) of the disease (RRR 5.82, 95% CI 4.14–8.16, p

Date: 2016
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0157721 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 57721&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0157721

DOI: 10.1371/journal.pone.0157721

Access Statistics for this article

More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().